guidance.fyi
Company, ticker, metric, guidance, or anything said
VerifiedNumbers checked and claims independently audited

Q1 FY27 concall · earnings callBASF India Limited

The company delivered a record first quarter with revenue up 29% and PBT up 166%, while executing portfolio simplification through the demerger of the agricultural solutions business and sale of the coatings business.

Positive tone4-minute briefPublished 6 days after the call

Numbers
MetricThis quarterChangeFive-quarter trend
Q1 FY27 Revenue₹4,998 Cr+29%
Q1 FY27 PBT (before exceptional items)₹499 Cr+166%
FY26 Revenue₹15,539 Cr+2%
FY26 PBT (before exceptional items)₹564 Cr-9%
Dividend per share (FY26)INR25—
Financials

From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.

QuarterRevenueNet profit (PAT)Basic EPS
Q3 FY25₹3,758.67 Cr+13% YoY-11.5% QoQ₹103.55 Cr-26.1% YoY-19.1% QoQ₹23.90-26% YoY-19.3% QoQ
Q2 FY25₹4,247.72 Cr— YoY+7.1% QoQ₹127.93 Cr— YoY-42% QoQ₹29.60— YoY-42% QoQ
Q1 FY25₹3,966.90 Cr— YoY+18.1% QoQ₹220.57 Cr— YoY+36.6% QoQ₹51.00— YoY+36.7% QoQ
Q4 FY24₹3,359.97 Cr— YoY+1% QoQ₹161.43 Cr— YoY+15.3% QoQ₹37.30— YoY+15.5% QoQ
Q3 FY24₹3,326.26 Cr— YoY— QoQ₹140.06 Cr— YoY— QoQ₹32.30— YoY— QoQ
TL;DR
  • Revenue increased 29% YoY in Q1 FY27.
  • Profit before tax and before exceptional items increased 166% YoY in Q1 FY27.
  • Demerger of agricultural solutions approved; listing targeted for first half of 2027.
  • Coatings business sale completed; proceeds of ~INR230 crores received.
  • Key investments like Cellasto expansion in Dahej are on track.
  • Renewable energy share in manufacturing expected to reach 75-80%.
Said on the call

“Our revenue experienced an increase of 29% from INR3,875 crores to INR4,998 crores owing to higher volumes and better price realization. On the profitability front, our profit before tax and before exceptional items increased by 166% from INR188 crores to INR499 crores.”

Alexander Gerding
From the Q&A
TopicWhat management said
Demerger & Portfolio StrategyManagement stated the demerger aims to unlock shareholder value and align with 'empowerment, simplification and differentiation', making the ag business a standalone pure-play. The listing of the new entity (BASIL) is targeted for the first half of 2027, subject to approvals. They clarified that post-demerger, the remaining entity will focus on strengthening its core businesses.
Capacity Utilization & CapexOverall capacity utilization was reported at 82-87% for FY26. Key growth investments include the Cellasto expansion in Dahej (INR104 crores work-in-progress) and a new dispersion line in Mangalore (INR5.6 crores work-in-progress). The Cellasto facility is expected to go live by end of 2026.
Market Share & CompetitorsManagement named competitors segment-wise (e.g., Bayer, Syngenta in agchem; Dow, Covestro in polyurethanes). They stated the aim is to be top-tier in each segment and shared that the ag business market share has grown to around 7% from 3% a few years ago.
Macro & Geopolitical ImpactManagement acknowledged higher input costs due to geopolitical issues and a delayed monsoon impacting herbicide sprays, making the second half difficult to predict. However, they highlighted a strong Q1 performance and noted over 90% of import payables are hedged to manage currency volatility.
Export & Financial DetailsExport sales were 2-2.5% of total sales (INR403 crores in FY26). R&D spend was INR47.8 million. Cash balance was INR869 crores as of March 31, 2026. There are no current plans for a stock split.
Sustainability & CSRRenewable energy share across manufacturing sites is expected to reach 75-80% through partnerships like Clean Max. CSR spend for FY27 is planned at INR13.16 crores. The company aims for net zero CO2 emissions by 2050.
Guidance
  • Target listing of demerged agricultural solutions entity (BASIL) in the first half of 2027.
  • Expect Cellasto expansion in Dahej to go live by the end of 2026.
  • Expect new dispersion production line in Mangalore to go live by the end of 2027.
  • Aim to increase renewable energy share in manufacturing to 75-80%.
  • Do not provide forecasts or outlook regarding future business performance or financial results.
Source
Same sector

Others in Chemicals

All Chemicals →
  • Prasol Chemicals LimitedQ1 FY27Positive tone

    Q1 FY27 was exceptionally strong on inventory gains from West Asia-led acetone price rises, while underlying mid-single-digit volume growth remained healthy and management guided for INR1,550 crores to INR1,650 crores revenue in FY27 with normalization of margins ahead.

    Revenue from operations - Q1 FY27
    ₹433.6 Cra growth of 35.7% YoY
    Gross margin - Q1 FY27
    37.9%compared to 30% in Q1 FY26
    PRASOLCHEMChemicalsVerified brief5 guidance items
  • Solar Industries India LimitedQ1 FY27Positive tone

    Solar Industries agreed to acquire South Africa's Omnia Holdings for cash funded by debt and internal accruals to build an integrated global explosives and blasting solutions platform with backward integration into ammonium nitrate.

    Solar projected current year revenue
    ₹14,000 Cr
    Solar projected FY28 revenue
    ₹16,500 Cr
    SOLARINDSChemicalsVerified brief4 guidance items
  • Indo Borax & Chemicals LimitedQ1 FY27Positive tone

    Q1 FY27 delivered 31.34% revenue growth and 59.31% profit growth from better utilization and realizations while Indo Borax moved to acquire 64.26% of Kronox Lab Sciences.

    Operating revenue
    ₹70.36 Cr+31.34% increase against ₹53.57 Cr in Q1 FY 26
    EBITDA
    ₹19.8 Crup by 62.16% vs ₹12.21 Cr in Q1 FY 26
    INDOBORAXChemicalsVerified brief5 guidance items
  • Stallion India started FY27 with strong profit growth and is focusing on executing key expansion projects, including its high-purity helium and R32 manufacturing facilities, to drive future growth.

    Total Revenue
    124.68 crores12.78%
    EBITDA
    25.27 crore75.85%
    STALLIONChemicalsVerified brief4 guidance items
  • Ester Industries LimitedQ1 FY27Positive tone

    The quarter was driven by a strong rebound in the BOPET film business due to improved industry pricing and capacity utilization, leading to a significant turnaround in consolidated profitability.

    Consolidated Total Income
    ₹441.9 Cr27.4%
    Consolidated EBITDA
    ₹58.9 Cr103.4%
    ESTERChemicalsVerified brief4 guidance items